FRESENIUS MEDICAL CARE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.1 EUR | -0.85% |
|
-0.11% | -6.88% |
| 11:12am | Fresenius at a two-month high - Tyenne launch and fantasy figures | DP |
| 10:28am | Fresenius at two-month high - Tyenne launch a milestone | DP |
| Sales 2024 * | 19.7B 20.94B | Sales 2025 * | 20.41B 21.7B | Capitalization | 10.39B 11.04B |
|---|---|---|---|---|---|
| Net income 2024 * | 727M 773M | Net income 2025 * | 973M 1.03B | EV / Sales 2024 * | 1.04 x |
| Net Debt 2024 * | 10.07B 10.71B | Net Debt 2025 * | 9.47B 10.07B | EV / Sales 2025 * | 0.97 x |
| P/E ratio 2024 * |
14.3
x | P/E ratio 2025 * |
10.7
x | Employees | 119,845 |
| Yield 2024 * |
3.12% | Yield 2025 * |
3.7% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | -0.85% | ||
| 1 week | -0.11% | ||
| Current month | -0.84% | ||
| 1 month | +1.29% | ||
| 3 months | -2.54% | ||
| 6 months | +7.38% | ||
| Current year | -6.88% |
1 week
34.87
36.27
1 month
34.1236.27
Current year
33.8841.62
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 35.35 | -0.14% | 67 863 |
| 24-04-15 | 35.4 | -0.11% | 252,017 |
| 24-04-12 | 35.44 | +0.37% | 177,434 |
| 24-04-11 | 35.31 | -1.06% | 198,944 |
| 24-04-10 | 35.69 | +0.85% | 365,949 |
Delayed Quote Xetra, April 16, 2024 at 09:09 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-06
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.4
EUR
Average target price
38.95
EUR
Spread / Average Target
+10.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.88% | 11.04B | |
| -12.66% | 86.92B | |
| +19.19% | 85.34B | |
| +12.75% | 29.88B | |
| -10.55% | 17.1B | |
| -5.66% | 15.24B | |
| -6.70% | 14.29B | |
| +1.02% | 12.38B | |
| -31.58% | 12.1B | |
| +24.05% | 11.4B |
- Stock Market
- Equities
- FME Stock
